多発性硬化症治療の世界市場（～2026年）

• 英文タイトル：Global Multiple Sclerosis Treatment Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY03867 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は多発性硬化症治療のグローバル市場について調査・分析したレポートです。種類別（磁気共鳴画像法、簡易電気刺激検査、腰椎穿刺）市場規模、用途別（獣医病院、獣医クリニック、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別多発性硬化症治療の競争状況、市場シェア ・世界の多発性硬化症治療市場：種類別市場規模 2015年-2020年（磁気共鳴画像法、簡易電気刺激検査、腰椎穿刺） ・世界の多発性硬化症治療市場：種類別市場規模予測 2021年-2026年（磁気共鳴画像法、簡易電気刺激検査、腰椎穿刺） ・世界の多発性硬化症治療市場：用途別市場規模 2015年-2020年（獣医病院、獣医クリニック、研究機関） ・世界の多発性硬化症治療市場：用途別市場規模予測 2021年-2026年（獣医病院、獣医クリニック、研究機関） ・北米の多発性硬化症治療市場分析：米国、カナダ ・ヨーロッパの多発性硬化症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの多発性硬化症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の多発性硬化症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの多発性硬化症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Teva Pharmaceutical Industries、Bayer、Biogen Idec、Pfizer、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Multiple sclerosis (MS) is a demyelinating disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Specific symptoms can include double vision, blindness in one eye, muscle weakness, trouble with sensation, or trouble with coordination. MS takes several forms, with new symptoms either occurring in isolated attacks (relapsing forms) or building up over time (progressive forms). Between attacks, symptoms may disappear completely; however, permanent neurological problems often remain, especially as the disease advances.
Although there is no known cure for multiple sclerosis, several therapies have proven helpful. The primary aims of therapy are returning function after an attack, preventing new attacks, and preventing disability. Starting medications is generally recommended in people after the first attack when more than two lesions are seen on MRI.

Market Analysis and Insights: Global Multiple Sclerosis Treatment Market
The global Multiple Sclerosis Treatment market size is projected to reach US$ 17400 million by 2026, from US$ 17030 million in 2020, at a CAGR of 2.0%% during 2021-2026.

Global Multiple Sclerosis Treatment Scope and Market Size
Multiple Sclerosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Multiple Sclerosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Teva Pharmaceutical Industries
Bayer
Biogen Idec
Pfizer
Novartis
…

Market segment by Type, the product can be split into
Magnetic Resonance Imaging
Simple Electrical Stimulation Tests
Lumbar Puncture
Market segment by Application, split into
Veterinary Hospitals
Veterinary Clinics
Research Institutions

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Multiple Sclerosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Multiple Sclerosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Magnetic Resonance Imaging
1.4.3 Simple Electrical Stimulation Tests
1.4.4 Lumbar Puncture
1.5 Market by Application
1.5.1 Global Multiple Sclerosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Veterinary Hospitals
1.5.3 Veterinary Clinics
1.5.4 Research Institutions
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Multiple Sclerosis Treatment Market Perspective (2015-2026)
2.2 Global Multiple Sclerosis Treatment Growth Trends by Regions
2.2.1 Multiple Sclerosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Multiple Sclerosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Multiple Sclerosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Multiple Sclerosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Multiple Sclerosis Treatment Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Multiple Sclerosis Treatment Players by Market Size
3.1.1 Global Top Multiple Sclerosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Multiple Sclerosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Multiple Sclerosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Multiple Sclerosis Treatment Market Concentration Ratio
3.2.1 Global Multiple Sclerosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Multiple Sclerosis Treatment Revenue in 2019
3.3 Multiple Sclerosis Treatment Key Players Head office and Area Served
3.4 Key Players Multiple Sclerosis Treatment Product Solution and Service
3.5 Date of Enter into Multiple Sclerosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Multiple Sclerosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Multiple Sclerosis Treatment Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Multiple Sclerosis Treatment Market Size by Application (2015-2020)
5.2 Global Multiple Sclerosis Treatment Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Multiple Sclerosis Treatment Market Size (2015-2020)
6.2 Multiple Sclerosis Treatment Key Players in North America (2019-2020)
6.3 North America Multiple Sclerosis Treatment Market Size by Type (2015-2020)
6.4 North America Multiple Sclerosis Treatment Market Size by Application (2015-2020)

7 Europe
7.1 Europe Multiple Sclerosis Treatment Market Size (2015-2020)
7.2 Multiple Sclerosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Multiple Sclerosis Treatment Market Size by Type (2015-2020)
7.4 Europe Multiple Sclerosis Treatment Market Size by Application (2015-2020)

8 China
8.1 China Multiple Sclerosis Treatment Market Size (2015-2020)
8.2 Multiple Sclerosis Treatment Key Players in China (2019-2020)
8.3 China Multiple Sclerosis Treatment Market Size by Type (2015-2020)
8.4 China Multiple Sclerosis Treatment Market Size by Application (2015-2020)

9 Japan
9.1 Japan Multiple Sclerosis Treatment Market Size (2015-2020)
9.2 Multiple Sclerosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Multiple Sclerosis Treatment Market Size by Type (2015-2020)
9.4 Japan Multiple Sclerosis Treatment Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Multiple Sclerosis Treatment Market Size (2015-2020)
10.2 Multiple Sclerosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Multiple Sclerosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Multiple Sclerosis Treatment Market Size by Application (2015-2020)

11 India
11.1 India Multiple Sclerosis Treatment Market Size (2015-2020)
11.2 Multiple Sclerosis Treatment Key Players in India (2019-2020)
11.3 India Multiple Sclerosis Treatment Market Size by Type (2015-2020)
11.4 India Multiple Sclerosis Treatment Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Multiple Sclerosis Treatment Market Size (2015-2020)
12.2 Multiple Sclerosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Multiple Sclerosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Multiple Sclerosis Treatment Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Teva Pharmaceutical Industries
13.1.1 Teva Pharmaceutical Industries Company Details
13.1.2 Teva Pharmaceutical Industries Business Overview
13.1.3 Teva Pharmaceutical Industries Multiple Sclerosis Treatment Introduction
13.1.4 Teva Pharmaceutical Industries Revenue in Multiple Sclerosis Treatment Business (2015-2020))
13.1.5 Teva Pharmaceutical Industries Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Multiple Sclerosis Treatment Introduction
13.2.4 Bayer Revenue in Multiple Sclerosis Treatment Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Biogen Idec
13.3.1 Biogen Idec Company Details
13.3.2 Biogen Idec Business Overview
13.3.3 Biogen Idec Multiple Sclerosis Treatment Introduction
13.3.4 Biogen Idec Revenue in Multiple Sclerosis Treatment Business (2015-2020)
13.3.5 Biogen Idec Recent Development
13.4 Pfizer
13.4.1 Pfizer Company Details
13.4.2 Pfizer Business Overview
13.4.3 Pfizer Multiple Sclerosis Treatment Introduction
13.4.4 Pfizer Revenue in Multiple Sclerosis Treatment Business (2015-2020)
13.4.5 Pfizer Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Multiple Sclerosis Treatment Introduction
13.5.4 Novartis Revenue in Multiple Sclerosis Treatment Business (2015-2020)
13.5.5 Novartis Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Multiple Sclerosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Multiple Sclerosis Treatment Revenue
Table 3. Ranking of Global Top Multiple Sclerosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Multiple Sclerosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Magnetic Resonance Imaging
Table 6. Key Players of Simple Electrical Stimulation Tests
Table 7. Key Players of Lumbar Puncture
Table 8. Global Multiple Sclerosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Multiple Sclerosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Multiple Sclerosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Multiple Sclerosis Treatment Market Share by Regions (2015-2020)
Table 12. Global Multiple Sclerosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Multiple Sclerosis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Multiple Sclerosis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Multiple Sclerosis Treatment Players
Table 19. Global Multiple Sclerosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Multiple Sclerosis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Treatment as of 2019)
Table 22. Global Multiple Sclerosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Multiple Sclerosis Treatment Product Solution and Service
Table 25. Date of Enter into Multiple Sclerosis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Multiple Sclerosis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Multiple Sclerosis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Multiple Sclerosis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Multiple Sclerosis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Multiple Sclerosis Treatment Market Share (2019-2020)
Table 35. North America Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 37. North America Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Multiple Sclerosis Treatment Market Share (2019-2020)
Table 41. Europe Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 43. Europe Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Multiple Sclerosis Treatment Market Share (2019-2020)
Table 47. China Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 49. China Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Multiple Sclerosis Treatment Market Share (2019-2020)
Table 53. Japan Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 55. Japan Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Multiple Sclerosis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Multiple Sclerosis Treatment Market Share (2019-2020)
Table 65. India Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 67. India Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Multiple Sclerosis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Multiple Sclerosis Treatment Market Share (2019-2020)
Table 71. Central & South America Multiple Sclerosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Multiple Sclerosis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Multiple Sclerosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Multiple Sclerosis Treatment Market Share by Application (2015-2020)
Table 75. Teva Pharmaceutical Industries Company Details
Table 76. Teva Pharmaceutical Industries Business Overview
Table 77. Teva Pharmaceutical Industries Product
Table 78. Teva Pharmaceutical Industries Revenue in Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 79. Teva Pharmaceutical Industries Recent Development
Table 80. Bayer Company Details
Table 81. Bayer Business Overview
Table 82. Bayer Product
Table 83. Bayer Revenue in Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 84. Bayer Recent Development
Table 85. Biogen Idec Company Details
Table 86. Biogen Idec Business Overview
Table 87. Biogen Idec Product
Table 88. Biogen Idec Revenue in Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 89. Biogen Idec Recent Development
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Product
Table 93. Pfizer Revenue in Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 94. Pfizer Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Multiple Sclerosis Treatment Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Multiple Sclerosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Magnetic Resonance Imaging Features
Figure 3. Simple Electrical Stimulation Tests Features
Figure 4. Lumbar Puncture Features
Figure 5. Global Multiple Sclerosis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Veterinary Hospitals Case Studies
Figure 7. Veterinary Clinics Case Studies
Figure 8. Research Institutions Case Studies
Figure 9. Multiple Sclerosis Treatment Report Years Considered
Figure 10. Global Multiple Sclerosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Multiple Sclerosis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Multiple Sclerosis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Multiple Sclerosis Treatment Market Share by Players in 2019
Figure 15. Global Top Multiple Sclerosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Multiple Sclerosis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Multiple Sclerosis Treatment Revenue in 2019
Figure 17. North America Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Multiple Sclerosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

---